444 related articles for article (PubMed ID: 34508560)
1. Use of disease-modifying antirheumatic drugs and the subsequent risk of herpes zoster in older adults.
Qian J; Lassere MN; Heywood AE; Liu B
Rheumatology (Oxford); 2021 Nov; 60(11):5042-5051. PubMed ID: 34508560
[TBL] [Abstract][Full Text] [Related]
2. Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study.
Jeong S; Choi S; Park SM; Kim J; Ghang B; Lee EY
Arthritis Res Ther; 2022 Jul; 24(1):180. PubMed ID: 35902964
[TBL] [Abstract][Full Text] [Related]
3. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR
JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785
[TBL] [Abstract][Full Text] [Related]
4. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
Sepriano A; Kerschbaumer A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JW; Burmester GR; de Wit M; Falzon L; Landewé R
Ann Rheum Dis; 2020 Jun; 79(6):760-770. PubMed ID: 32033941
[TBL] [Abstract][Full Text] [Related]
5. Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs.
Wong SCT; Li IWS; Ng AHY; Lau CS; Chung HY
Int J Rheum Dis; 2020 Feb; 23(2):189-196. PubMed ID: 31489783
[TBL] [Abstract][Full Text] [Related]
6. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.
Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
Arthritis Rheum; 2007 Dec; 57(8):1431-8. PubMed ID: 18050184
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort.
Qian J; Banks E; Macartney K; Heywood AE; Lassere MN; Liu B
Mayo Clin Proc; 2021 Nov; 96(11):2843-2853. PubMed ID: 34736610
[TBL] [Abstract][Full Text] [Related]
8. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
9. Psoriatic arthritis treatment and the risk of herpes zoster.
Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study.
Liu B; Heywood AE; Reekie J; Banks E; Kaldor JM; McIntyre P; Newall AT; Macintyre CR
Epidemiol Infect; 2015 Oct; 143(13):2871-81. PubMed ID: 25592769
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study.
Pan SW; Yen YF; Feng JY; Chuang PH; Su VY; Kou YR; Su WJ; Chan YJ
Br J Clin Pharmacol; 2020 Mar; 86(3):569-579. PubMed ID: 31633826
[TBL] [Abstract][Full Text] [Related]
12. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
[TBL] [Abstract][Full Text] [Related]
13. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
14. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.
Ramiro S; Gaujoux-Viala C; Nam JL; Smolen JS; Buch M; Gossec L; van der Heijde D; Winthrop K; Landewé R
Ann Rheum Dis; 2014 Mar; 73(3):529-35. PubMed ID: 24401994
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
Mok CC; Ho LY; Tse SM; Chan KL; To CH
Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
[TBL] [Abstract][Full Text] [Related]
16. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Liao TL; Chen YM; Liu HJ; Chen DY
BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
[TBL] [Abstract][Full Text] [Related]
17. The risk of herpes zoster in patients with ankylosing spondylitis: Analysis of the Korean National Health Insurance Service - Sample cohort database.
Lim DH; Kim YJ; Kim SO; Hong S; Lee CK; Yoo B; Kim YG
Mod Rheumatol; 2018 Jan; 28(1):168-173. PubMed ID: 28548546
[TBL] [Abstract][Full Text] [Related]
18. Risk of Herpes Zoster Prior to and Following Cancer Diagnosis and Treatment: A Population-Based Prospective Cohort Study.
Qian J; Heywood AE; Karki S; Banks E; Macartney K; Chantrill L; Liu B
J Infect Dis; 2019 Jun; 220(1):3-11. PubMed ID: 30544213
[TBL] [Abstract][Full Text] [Related]
19. Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study.
Harada S; Sakai R; Hirano F; Miyasaka N; Harigai M;
J Rheumatol; 2017 Jul; 44(7):988-995. PubMed ID: 28412701
[TBL] [Abstract][Full Text] [Related]
20. Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis.
Grijalva CG; Chung CP; Arbogast PG; Stein CM; Mitchel EF; Griffin MR
Med Care; 2007 Oct; 45(10 Supl 2):S66-76. PubMed ID: 17909386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
